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Introduction and objectives 
Brucella spp. infects multiple animal species, including cattle, pigs, small ruminants, camels, water 
buffaloes and yaks. Different species of Brucella infect different animal species, but most have the 
potential to infect humans, with some species of the organism causing more disease than others. 
Brucella infection rates in some developing countries can reach greater than 10% of the human 
population, making it a serious public health disease. Brucella causes disease in animals, impacting 
production, causing abortions in pregnant females and reducing male fertility. The most common 
method by which humans are infected is through ingesting unprocessed milk products from infected 
animals. However, direct contact with infected animals and meat can also be a source. Therefore, the 
goal of this workshop was to work with appropriate personnel to develop improved diagnostic 
surveillance techniques and control strategies for livestock on a country basis. Specific topics that 
were covered included: 
 
 Transmission of infection from animals to humans (public health) 
 Epidemiology: prevalence, impacts and transmission among animals 
 Laboratory biosafety practices 
 Diagnostic assays: serology and organism identification to assist in developing surveillance 
programs 
 Vaccination strategies 
 Policy 
 
In addition, potential research collaborations for Brucella were investigated. Collaborative research will 
provide long-term engagement programs for improving the control of brucellosis in the various 
countries and provide important support to scientists working on Brucella. The workshop provided the 
organizers and participants with critical information on this frequent human pathogen contracted 
from domestic animals. 
 
The anticipated outcomes of the meeting included: 
 Knowledge and understanding of the status of Brucella surveillance and control in the 
participating African countries 
 Identification of gaps in surveillance, monitoring and control in animals 
 Potential strategies to begin implementing surveillance and possible control strategies 
 
Participants 
There were 69 participants including the organizing committee and invited speakers. The participants 
and organizers were from 16 countries, 13 of which were in Africa. The list of participants is included in 
Appendix 1. 
 
Overview of the workshop 
A copy of the workshop agenda is included in Appendix 2. 
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Day 1, Tuesday 29 January 2013 
The meeting was opened with welcoming remarks from Eileen Thacker as the head of the organizing 
committee, Azage Tegegne representing CGIAR (for ILRI), Abdelkhalik Montasser for the African Union 
– Interafrican Bureau for Animal Resources (AU-IBAR), Eileen Herrera for USDA–ARS and John Graham 
for USAID.  
 
The morning session included overviews covering all aspects of brucellosis that would be the topic of 
discussion throughout the workshop. Online links to the presentations are included in Appendix 4. 
  
Eileen Thacker gave an introductory presentation on “Brucellosis: The bugs and the disease”.  The 
history, clinical signs, treatment and basic control strategies were covered with the take-home 
message that to prevent brucellosis in humans, we must eradicate it from animal populations. 
 
Steve Hennager gave a presentation on the “Differential diagnosis of brucellosis serological 
reactions”. He discussed antibody detection assays for milk and serum and the positive and negatives 
of each type of test. 
 
John Kaneene presented on the “Epidemiology of brucellosis in ruminants: The basics and dynamics 
of the disease”. He discussed the host ruminants as well as the reservoir hosts that can maintain and 
transmit the infection to other species. He discussed modes of transmission, both to other animals 
and humans. Outbreak investigations and the steps needed to conduct a successful investigation were 
covered. He concluded with outbreak control and monitoring methods to evaluate the effectiveness of 
the control measures. 
 
Anani Adeniran Bankolé presented on “Brucellosis risk assessment”. He discussed using risk analysis 
as a tool to provide decision-makers with an objective and documented assessment. Risk assessment 
requirements for brucellosis included imports (commodities), surveillance (also related to importation), 
microbiological assessment for food safety, and human infection (primarily from food). 
 
Steven Olsen gave a presentation on “Beneficial approaches for controlling brucellosis”. In his 
presentation, he discussed the components of a control program which would include surveillance, 
vaccination, quarantine or removal of infected animals (risk reduction), sanitation, trained personnel, 
complete and accurate records, movement control and regionalization of the control. He noted that 
usually vaccination for Brucella is controlled and vaccination alone will not eradicate brucellosis. He 
also discussed the basics of the other control strategies listed above. He summarized brucellosis 
control strategies as needing to be coordinated and committed within a regulatory framework. The 
benefits of control include reduced human disease, greater economic returns for livestock owners and 
possible trade opportunities. 
 
Bassirou Bonfoh gave a presentation on the “Economics of brucellosis”. He discussed the ongoing 
research on brucellosis in his institute (Centre Suisse de Recherches Scientifique, CSRS) and the 
importance of livestock in assisting people to get out of poverty and providing protein. He covered 
possible methods to determine the economic considerations and the link of disease data to 
production and human health costs. The presentation included a very comprehensive discussion 
about the economic cost/benefit of controlling brucellosis. 
 
Joseph P. Kozlovac presented on “Laboratory biosafety and biosecurity issues related to Brucella 
research and diagnostics”. Since brucellosis is the most common laboratory acquired infection, he 
discussed the types of safety techniques and equipment needed for diagnostics and research. This 
included defining safety risk groups and measures to control aerosol spread. He also discussed 
personal protective equipment, occupational health and surveillance measures that could also help 
minimize the risk of infection to laboratory workers. 
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Stella Kiambi discussed “One Health units and brucellosis in Kenya”. In her presentation, she began 
by describing Kenya‟s geographic and demographic statistics, including the number of animals in the 
country. She defined One Health as “the collaborative efforts of multiple disciplines working locally, 
nationally and globally to attain optimal health for people, animals and the environment” (AVMA 
2007). She went on to discuss how many diseases are zoonotic in nature and therefore, the Zoonotic 
Disease Unit (ZDU) has been established to collaborate on controlling these diseases. The ZDU is a 
joint effort by the Kenyan Ministries of Public Health and Sanitation, and Livestock Development. The 
ZDU has been conducting a study of brucellosis using a seroprevalence survey in animals and humans 
to identify the factors of infections and determine the socio-economic impact of the disease in both 
populations. They are currently in the first phase of the study and it is going well. 
 
Abdelkhalik M. Montasser gave a presentation on “Background of AU-IBAR and brucellosis: Past, 
present and future in the Middle East and Africa”. He discussed the mission/mandate and goals of AU-
IBAR in providing leadership and support in the development and utilization of animals to enhance 
economic growth, food and nutrition security and poverty reduction in Africa. AU-IBAR‟s strategic 
programs include reducing transboundary and zoonotic diseases, conserving and sustaining natural 
resources, improving investment and competitiveness of animal resources, improving knowledge 
management and facilitating development of policies and institutional capacities for improving animal 
resource utilization. He provided interesting statistics on brucellosis in Africa where 40 of 54 African 
countries are known or suspected to be positive, 20 countries consider it a major problem, 10 a 
moderate problem and 10 a minor problem. All Middle Eastern countries have brucellosis so regional 
control is needed. He reiterated the need for improved surveillance and control, primarily through 
vaccination. In conclusion, he discussed possible future control strategies that would be important to 
improve the overall health of animals and humans. 
 
Delia Grace provided an “Overview to the Meeting”. She discussed how brucellosis had been 
identified in early skeletal remains in South Africa and has remained a problem since. Africa is an 
agrarian society with many farmers, livestock and consumers, and meat is a preferred source of 
protein. Women play an important role in livestock farming, and wildlife is uniquely important and can 
be a risk. Overall, there is a high level of apparent disease yet low levels of reporting. There have been 
over 800 studies on brucellosis in Africa with an average prevalence in animals of 10.5% and 8% in 
humans. Brucella has been isolated from almost every species of animal. The goal of this workshop 
was to begin identifying the gaps in knowledge and share experiences in strategies that work and 
those that haven‟t been successful. She hoped that the workshop would lead to plans, proposals and 
new investments in addressing brucellosis in Africa. 
 
After the opening session in the morning, the participants attended two breakout sessions. The first 
session had four breakout groups, namely,  
 Diagnostics: Serological screening tests;  
 Epidemiology: Large ruminants;  
 Vaccination and control for small ruminants; and  
 Biosafety. 
 
The second session had three breakout groups:  
 Diagnostics: Confirmatory tests; 
 Epidemiology: Small ruminants; and 
 Vaccination and control for large ruminants.  
 
Summary reports of the breakout sessions are included in Appendix 3. 
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Day 2, Wednesday 30 January 2013 
The second day started with a general session focused on research. The research plenary session was 
opened by Eileen Thacker who welcomed the participants back to the meeting. This was followed by 
presentations from a few selected speakers: 
 
Steven Olsen provided an overview of his research on brucellosis. He discussed cattle and bison 
vaccine work, Brucella in feral swine and the differences in the immune responses to vaccines he has 
found with different species of ruminants. 
 
John Kaneene discussed an “Overview of Michigan State University brucellosis research in Africa”. He 
has performed research in Ghana, Tanzania and Uganda. His research in Uganda included a 
“Comparative study of brucellosis in livestock and humans in southwestern Uganda” in collaboration 
with Makerere University. In Tanzania, his research was on “The prevalence of brucellosis in cattle, 
goats and humans in Naitolia, Northern Tanzania” in collaboration with Sokoine University of 
Agriculture. In Ghana, the research was “A Comparative study of brucellosis in local and imported 
cattle breeds” with the University of Ghana, Noguchi Memorial Institute for Medical Research. 
 
Eric Fèvre and William de Glanville presented on research on zoonoses in western Kenya and 
surprising results from investigations on brucellosis prevalence. Fèvre discussed a study in the western 
Kenya where smallholder crop-livestock production systems were sampled intensively and 
comprehensively over a 2.5 year period. He showed a very detailed sample flow chart for collecting 
and recording samples from the field and slaughter houses. A cross-sectional survey was conducted – 
sampling cattle, pigs and goats in approximately 450 households – along with a questionnaire. Full 
clinical examinations were performed which included collection of blood and serum and faeces along 
with biobanking material for genetic studies. In collaboration with the Kenya Medical Research 
Institute (KEMRI), an additional cross-sectional study of human samples was conducted from people 
that did and did not live with livestock. De Glanville reported on a serological study for brucellosis 
using a lateral flow assay as a primary screening test. In the study, 2116 people and 893 cattle were 
tested for Brucella antibodies. In these studies, brucellosis appeared to have a low incidence and it 
was suggested that the incidence of brucellosis was being over diagnosed. 
 
Edward Ssekawojwa, Uganda, presented on “Risk factors for Brucella seropositivity in cattle, goats 
and humans in Mbarara”. Mbarara is a major livestock producing area with both pastoral and agro-
pastoral types of livestock management systems. In the study, 1535 cattle and 812 goats from 98 
farms were sampled. In addition, 161 humans from Brucella-positive farms and 168 individuals from 
Kampala were tested serologically. Animal samples were screened using the Rose Bengal assay with 
confirmation using a cELISA test. Human samples were tested using plate and standard tube 
agglutination tests and the cELISA. The percentages of positive animals and herds were reported. It 
was determined that several factors – including a pastoral production system, herd size and incidence 
of abortion – were risk factors for livestock. Consumption of raw, unboiled milk was significantly 
associated with seropositivity in humans. Recommendations to reduce the incidence of human 
brucellosis included public awareness, discouraging the consumption of raw milk and addressing the 
pastoral production system.  
 
Tujuba Jergefa Oncho presented on an epidemiological study of bovine brucellosis in Ethiopia. The 
level of brucellosis in Ethiopia is not well established due to conflicting reports. The study included 
three districts in Ethiopia and consisted of sampling local cattle over six months of age. The study 
included serum from 1238 animals and 176 households across three types of environment: lowlands, 
mid highlands and highlands. Rose Bengal plate and complement fixation tests were used to assay the 
samples. A questionnaire was included in the study. The study found that the overall seropositivity of 
bovine Brucella was low but varied by region. Breed and management practices were found to be 
important risk factors. There was low public awareness of brucellosis and clinical disease. It was 
recommended that a comprehensive and coordinated epidemiological study be performed in Ethiopia 
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to formulate a policy. In addition, regular testing of animals, testing and culling practices, and 
increased education are needed. 
 
William Mwebembezi presented a case study on the “Prevalence of antibodies against Brucella 
among breeding goats in relation to source”. The government of Uganda has a program to supply 
breeding goats. There has been past evidence of Brucella in the area, so it was proposed to carry out 
an audit and recommend animals for purchase. The objective was to screen potential breeding goats 
for brucellosis and to compare the prevalence of infection between goats obtained from markets and 
those from farms. Goats in the study were identified by ear tags and tested for Brucella by the Rose 
Bengal plate test. A total of 7739 goats were tested and 13.4% were positive. There was a wide range 
in disease prevalence and source of goats was found to influence disease status, with goats from 
markets having a higher percentage of seropositivity. 
 
After the plenary research session in the morning, two additional breakout session periods were held, 
with a repeat of the sessions held the previous day to enable participants to attend as many different 
sessions as possible. The reports of the breakout sessions are included in Appendix 3. 
 
On the final day, 31 January, the session was chaired by Bassirou Bonfoh from CSRS. Presentations 
were given by representatives of the three organizing institutes.  
 
USDA: Eileen Thacker 
The way forward following this workshop has to be directed by the African participants. USDA does 
not have a program specifically for supporting international research, but it has a program on 
international co-operation. Through this program, funding sources can often be identified for 
developing collaborations. The USDA Animal Plant Health Inspection Service (APHIS) can provide 
support and training. Brucellosis is very important to the USDA. From past experience, we know 
eradication is not easy. Participants can count on USDA support as they go forward. 
 
USAID: Joyce Turk 
She thanked the participants for their energetic and enthusiastic participation in the workshop which 
demonstrated their serious interest as well as willingness to learn from each other and work together. 
USAID employs one veterinarian in headquarters in the Disaster, Conflict and Humanitarian Assistance 
office as well as Yirgelem Gebremelski in USAID Addis, Jeffrey Austin and Andrew Clark in the East 
Africa Regional office, Nairobi and Connie Bacon in the West Africa regional office, Senegal.  
 
Bilateral USAID offices fund country-specific programs that align with Feed the Future country 
strategies, a few of which have livestock components. USAID Washington funds a collaborative 
livestock research program, Adapting Livestock Systems to Climate Change, which is funding two 
Ethiopian and six Kenyan early career research scholars. Two of them are doing research on 
brucellosis. Although USAID funds specific country-level projects, participants were encouraged to 
contact or link with the USAID veterinarians named above for more specific technical or program 
design support. 
 
ILRI: Delia Grace 
ILRI is an international research organization that works with developing country partners to increase 
the benefits of livestock to poor people and mitigate the risks associated with livestock, including 
zoonoses. As such, ILRI is not a donor organization but can work with partners to jointly develop 
research proposals and seek funding. ILRI leads a major CGIAR research program on “More meat, milk 
and fish by and for the poor”. This focuses on nine value chains and for four of these, brucellosis is a 
major constraint (dairy in Tanzania, dairy in India, shoats in Mali and shoats in Ethiopia). ILRI also is 
involved in another CGIAR research program which is led by the International Food Policy Research 
Institute in Washington DC; ILRI leads the component on prevention and control of agriculture-
associated diseases.   
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Region/country working groups 
The next part of the session consisted of presenting group work by countries or regions. Each group 
was asked to identify their top two priorities in the following areas: 
 
1. Technical cooperation and capacity strengthening 
2. Research and evidence generation 
3. Coordination, networking and knowledge sharing 
 
Ethiopia 
Technical cooperation and capacity strengthening 
1. Technical training especially in the areas of biosafety, biosecurity, equipment and diagnostics 
2. Ethiopia has several existing laboratories and regional and international collaborations should 
be developed for capacity strengthening 
 
Research and evidence generation 
1. Epidemiological mapping of brucellosis prevalence, subtypes and risk factors 
2. Studies on the socio-economic impacts of disease including public health inputs  
 
Coordination, networking and knowledge sharing 
1. Linkage nationally among ministries of education, agriculture and health; research institutes; 
health centres and development partners and regional linkages with East African countries 
with a focus on transboundary animal diseases 
2. Establish a national forum for zoonotic disease from community to policymakers following the 
model of avian influenza and share the experience of Kenya 
 
Kenya 
Technical cooperation and capacity strengthening 
1. Encouraging collaboration between medical and veterinary sectors. It was notable that 
veterinary diagnostics are more advanced than those used by human health. One Health 
collaboration could include discussion about shared resources. 
2. Training in epidemiology and diagnostics for technicians and academics; expanded to 
workshops and scientific meetings; One Health; needs assessment to identify areas. 
 
Research and evidence generation 
1. Conduct risk mapping for Kenya to identify where to deploy interventions. 
2. Evaluating and validating rapid test kits within the Kenya.  
 
Coordination, networking and knowledge sharing 
1. Joint programs which could involve major stakeholders e.g. KEMRI, ILRI, Ministry of Health, 
Ministry of Agriculture. Could have a body to help link partners on brucellosis. 
2. Establish regional collaborations and can use the model of the rabies group. 
 
Uganda 
Technical cooperation and capacity strengthening 
1. Technical cooperation involving technical assistance, equipment, diagnostic kits, consumables 
and protective gear 
2. Capacity building in epidemiology and diagnostics in human and animal professionals 
 
Research and evidence generation 
1. National epidemiological study on brucellosis in human and animals in Uganda (baseline 
survey, risk assessment, risk mapping, bacteriological isolation and profiling) 
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2. Evaluation of brucellosis diagnostic tests and vaccines 
 
Coordination, networking and knowledge sharing 
1. Establish and operationalize a brucellosis communication strategy 
2. Establish and operationalize a One Health Secretariat in Uganda, with brucellosis as an entry 
point; can share information in one centre and be a point for collaboration and planning 
activities  
 
Tanzania 
Technical cooperation and capacity strengthening 
1. Skills for surveying brucellosis in the ecosystems of Tanzania: detection (field personnel); 
diagnosis (laboratory personnel); biosecurity and biosafety; reporting (information flow); 
response to findings; inter-laboratory cooperation (local, regional and international reference 
labs) 
2. Training in socio-economic aspects of brucellosis 
 
Research and evidence generation 
1. Study on ecology of brucellosis in various ecosystems in Tanzania: including livestock and 
wildlife and producing maps according to biotypes 
2. Establish social economic drivers of the disease and the impact of the disease on livestock 
(productivity) and human (burden) 
 
Coordination, networking and knowledge sharing 
1. Sharing of technical information among stakeholders, development partners through 
publication joint meeting, seminars. 
2. Enhance joint collaborative activity among key players/ one health approach. 
 
West Africa (Côte d’Ivoire, Togo, Senegal and Mauritania) 
Technical cooperation and capacity strengthening 
1. Training on epidemiology including sample collection, analysis and interpretation 
2. Capacity building of diagnostic capability and improving access to laboratory supplies  
 
Research and evidence generation 
1. Longitudinal epidemiological surveys in representative areas with maps and collection of 
economic data 
2. Identification of pathogens present and biovars 
 
Coordination, networking and knowledge sharing 
1. One Health strategy for brucellosis and other zoonoses in West Africa 
2. Mechanisms to improve communication between researcher and decision maker on true 
prevalence and impact. There is potential to use the Economic Community of West African 
States as a framework as there is a specialized commission with a mandate for zoonoses 
 
Nigeria 
Technical cooperation and capacity strengthening 
1. Upgrading of laboratory facilities and provision of equipment and reagents 
2. Training of personnel in current diagnostic techniques and biosafety. (There is work going on 
at many labs but not all are able to effectively conduct research) 
 
Research and evidence generation 
1. Using a nationally coordinated brucellosis survey design, determine baseline data for animal 
brucellosis in the country. This will include determining and characterizing the circulating 
Brucella species/biovars  
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2. Determine the burden of brucellosis in humans presenting with febrile conditions in hospitals 
and in those occupationally at risk  
 
Coordination, networking and knowledge sharing 
1. Formation of a brucellosis working group in Nigeria.  
2. Usage of all means of communication for sharing of research findings and knowledge among 
stakeholders 
 
Egypt, Somalia and South Africa 
Technical cooperation and capacity strengthening 
1. Establishment of a reference laboratory for brucellosis in Africa 
2. Harmonization of brucellosis control and strategies between neighbouring countries and 
sharing resources and training 
 
Research and evidence generation 
1. Biotyping and mapping of brucellosis and using the information for choosing vaccines 
2. Investigating the relationship between the disease in animals and people 
 
Coordination, networking and knowledge sharing 
1. Establishment of good networking between peripheral and central veterinary units for early 
reporting 
2. Raising awareness about the disease among the wider community and giving information on 
how to reduce risk 
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Summary of priorities 
 Capacity building Research Coordination 
Ethiopia 
Diagnostics 
Laboratory 
Surveys 
Socio economics 
Link sectors 
One Health forum 
Kenya 
One Health 
Epidemiology & diagnostics 
Surveys 
Rapid tests 
Joint programs 
Regional collaboration 
Uganda 
Equipment 
Diagnostics & epidemiology 
Surveys 
Tests & vaccines 
Communication  
One Health Forum 
Tanzania 
Diagnostics & epidemiology 
Socio-economics 
Survey 
Impact and drivers 
Sharing information 
One Health collaborations 
West Africa 
Epidemiology 
Diagnostics 
Surveys 
Economic data 
One Health Strategy 
Communication 
Nigeria 
Laboratory 
Diagnostics 
Surveys 
Economic & health 
Brucella working group 
Communication 
Egypt & Somalia 
Laboratory 
Control 
Surveys 
Health impacts 
Vet networks 
Communication 
 
 
The presentation of priorities was followed by discussion. Some of the points raised included: 
 
 The important role of international organizations in harmonizing legislation according to 
national priorities 
 Brucellosis is a transboundary disease and requires a regional approach 
 We still lack information on situation of brucellosis in each country 
 There is need to develop communication and network between countries 
 There is a lack of cooperation between Francophone and Anglophone countries and 
brucellosis can be an opportunity for improving collaboration 
 Coordination and knowledge sharing is required at a higher level. In the example of typhoid, 
also a neglected disease, collaboration led to better management.  
 There is a lot of information which is neither published nor shared.  
 A network to share information would be helpful 
 There is a need to harmonize trade regulations, movement permissions and control. There are 
many different regulations which impede trade.  
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The way forward: What are we going to do following the meeting? 
In the next part of the session, the facilitator asked groups by African region what they would do as 
the way forward. 
 
East Africa 
“We will convene into groups using administrative heads to meet and develop the details on the basis 
of which funding can be obtained and control started. We will take forward the findings and 
recommendations of the meeting. We will inform decision-makers on the importance of this disease 
and try and bring the stakeholders together. The next time we meet we will come with progress 
reports.” 
 
South Africa 
“Compared to some other countries, brucellosis is relatively under control but the meeting has 
highlighted some possible gaps. We have taken notes and will take these forward.” 
 
North Africa 
“We will contact colleagues in veterinary services to share the information we have received. We will 
try and start up a preliminary study for one or two states.” 
 
West Africa 
“There is much to do on this disease. We will transfer the information we have learned and try and 
maintain a relation between the West African countries for working together on brucellosis.” 
 
Final sum up from the Chair 
“Thank you for convening this very important brucellosis meeting. It has exceeded my 
expectations in the level of information sharing. My take home message: RB 51 and S19 are tools 
that can help for diagnostics and control. I came with many questions and I go home with more 
confidence in applying diagnostics and control. A second point is that for control, we are at 
different levels. I was re-assured that targeting high prevalence levels can help control. We have a 
challenge: the need for a platform for sharing information and we need to think how we can use 
the networks we have. If USDA has succeeded in bringing us here, we can do the same for the 
future. We need a toolkit for economic assessment for zoonotic diseases to go alongside the 
epidemiological tools. Finally, we thank USDA, ILRI and USAID for this meeting.” 
 
In conclusion, Eileen Herrera thanked the organizing committee (Eileen, Irlene, Joyce and Delia) and 
the ILRI staff who facilitated the meeting (Hailu, Rahel, Getachew and Isaiah). 
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Overall summary of the workshop 
Gaps 
 Lack of good, inexpensive, sensitive and specific diagnostic tests  
 Questionable quality control of diagnostic test results due to poor reagents and inexperienced 
technicians 
 Inability to type Brucella easily at the local level 
 Lack of comprehensive regional surveillance programs 
 Effective, safe, stable „Differentiating Infected from Vaccinated Animals‟ (DIVA) vaccines 
 
 
Needs 
 Reliable, sound data to convince governments to recognize the need to develop strategies to 
control brucellosis 
 Coordination of biosafety and laboratory training 
 Funding for research and surveillance to better understand Brucella spp. in various domestic 
and wild animals in Africa 
 More epidemiology for use in determining incidence and economic impact of the disease 
 Cold chain storage for vaccines 
 Education  
 Establish baseline levels of disease within countries and regions 
 
Challenges 
 Impress upon governments that brucellosis needs to be addressed through surveillance and 
control strategies 
 Provide adequate compensation to enable positive animals to be removed from the herds 
 Education to reduce consumption of raw milk and dairy products, overcoming cultural 
practices 
 Developing effective and affordable vaccine strategies at the regional level 
 Lack of a DIVA vaccine 
 
Way forward 
 Continue to develop a network of researchers/animal authorities to collaborate with research 
which will provide hard data for government use 
 One Health – utilizing community health and animal workers to educate and help develop 
control strategies 
 Work with governments and non-governmental organizations to coordinate surveillance and 
studies – avoid repetition and maximize the funds available 
 Network with countries, regions and/or governments that have developed successful 
strategies  
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Appendix 1: List of participants 
# Name Institution Title Country 
1 Abdelkhalik Montasser AU-IBAR Regional coordinator of VET-GOV 
program 
Kenya 
2 Abdisalam Warsane 
Mohamed 
Puntland Veterinary Board Chairman Somalia 
3 Abdu Hayghaimo  Ministry of Livestock and Fisheries 
Development 
Assistant director for veterinary 
public health, livestock products 
and inputs control 
Tanzania 
4 Abdulkadir Usman 
Junaidu 
Usmanu Danfodiyo, Department of 
Veterinary Public Health & 
Preventive Medicine 
Dean, Faculty of Veterinary 
Medicine 
Nigeria 
5 Alehegne Yirsaw Ministry of Agriculture, National 
Animal Health Diagnostic and 
Investigation Center 
Associate researcher, bacteriology 
lab head, deputy quality manager, 
coordinator of student externship 
MSC and PhD 
Ethiopia 
6 Amahyel Madu Gusi  National Veterinary Research 
Institute, Vom 
Senior veterinary research officer Nigeria 
7 Anani Adeniran Bankolé Direction of Livestock Services Veterinary inspector/head of meat 
inspection section 
Togo 
8 Andrew Clark USAID Foreign Agricultural Service, 
East Africa  
Consulting veterinarian USA 
9 Bassirou Bonfoh  Centre Suisse de Recherches 
Scientifiques 
Director general Côte d‟Ivoire 
10 Bernard Erima Makerere University Walter Reed 
Project 
Lab manager, emerging and re-
emerging infectious disease lab 
Uganda 
11 Charity Agada  University of Agriculture, Veterinary 
Department  
Lecturer Nigeria 
12 Charles Chris 
Rutebarika  
Ministry of Agriculture, Animal 
Industry & Fisheries 
Assistant commissioner, disease 
control 
Uganda 
13 Charles Njuguna World Health Organization (WHO) 
Integrated Disease Surveillance and 
Response 
National professional officer Kenya 
14 Chrisostom Ayebazibwe  Ministry of Agriculture, Animal 
Industry & Fisheries, National 
Animal Disease Diagnostics and 
Epidemiology Centre 
Senior veterinary officer Uganda 
15 Clet Wandui Masiga Agrobiodiversity and Biotechnology 
Program, Association for 
Strengthening Agricultural Research 
in Eastern and Central Africa 
Conservation biologist and 
geneticist 
Uganda 
16 Daniel P Mdetele Veterinary Investigation Centre Senior veterinary officer Tanzania 
17 David Ojigo Government of Kenya Epidemiologist/assistant director 
of veterinary services 
Kenya 
18 Delia Grace ILRI Program leader, Food Safety and 
Zoonoses and theme leader, 
Agriculture Associated Diseases, 
CGIAR Research Program on 
Agriculture for Nutrition and 
Health 
Kenya 
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19 Edward Ssekawojwa  Lvantonde District Local 
Government 
District veterinary officer Uganda 
20 Eileen Herrera USDA-ARS Deputy director, office of 
international research programs 
USA 
21 Eileen Thacker USDA-ARS National program leader, animal 
health 
USA 
22 Emmanuel 
Muchmbdziki Midzi 
Department of Agriculture & Rural 
Development, Veterinary Services 
State veterinarian South Africa 
23 Emmanuel Swai  Directorate of Veterinary Services Field epidemiologist Tanzania 
24 Eric Fèvre ILRI, University of Edinburgh Research fellow Kenya 
25 Eric Ogola Kenya Medical Research Institute Research officer Kenya 
26 Eric Osoro Ministry of Public Health and 
Sanitation 
Medical epidemiologist Kenya 
27 Farouk Mohammed  Jigawa Research Institute Chief research officer Nigeria 
28 Gabriel Shirima Tanzania Veterinary Lab Agency Principal veterinary research 
officer 
Tanzania 
29 Getachew Aburu  Ministry of Agriculture, National 
Animal Health Diagnostic and 
Investigation Centre 
Bacterial serology lab coordinator Ethiopia 
30 Halid Kirunda National Agricultural Research 
Organization 
Research officer Uganda 
31 Ihekerenma Okoli  Ministry of Agriculture, Department 
of Livestock 
Senior veterinary officer Nigeria 
32 Irlene Santos USDA-ARS International program analyst USA 
33 Isaiah Akuku ILRI Graduate fellow Kenya 
34 Isselmou Abdatt Centre National d'Elevage et de 
Recherches Vétérinaires (CNERV) 
Deputy Director Mauritania  
35 Jeffrey Austin USAID Sanitary and phytosanitary 
advisor, USAID East Africa 
USA 
36 John Kaneene Michigan State University Director, Center For Comparative 
Epidemiology/professor of 
epidemiology 
USA 
37 Jolly J.Hoona Busingye-
Kakira  
Ministry of Agriculture Principal veterinary officer Uganda 
38 Joseph P. Kozlovac USDA-ARS Agency biosafety officer USA 
39 Joyce Turk USAID/Bureau for Food Security Senior livestock advisor USA 
40 Kariuki Njenga  Integrated Human-Animal Health 
Program, Global Disease Detection, 
Kenya 
Virologist and Head Kenya 
41 Mbaye, Mbengue Institut Sénégalais de Recherches 
Agricoles, Laboratoire National 
d'Elevage et de Recherches 
Vétérinaires 
Scientist in Microbiology Senegal 
42 Mohamed Amar CNERV Head of department of 
Epidemiology 
Mauritania  
43 Obed Malangu 
Nyasebwa  
Veterinary Investigation Centre Officer in Charge Tanzania 
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44 Peninah Munyua  Centers for Disease Control (CDC) 
Kenya 
Epidemiologist Kenya 
45 Peter Mbatha Central Veterinary Lab Senior assistant director of 
veterinary services 
Kenya 
46 Qwari Bura Tanzania Veterinary Lab Agency Zonal lab manager/veterinary 
officer 
Tanzania  
47 Rees Murithi Mbaabu  Ministry of Livestock Development, 
Department of Veterinary Services 
Head, veterinary epidemiology & 
economics unit 
Kenya 
48 Reuben Ocholi National Veterinary Research 
Institute, Vom 
Director, Quality Assurance Nigeria 
49 Roger Pellé  ILRI Molecular biologist and scientist,  
vaccines and diagnostics 
Kenya 
50 Ronald Bameka  Kiruhura District Government District veterinary officer Uganda 
51 Rosekellen Njiru ILRI Senior administrative assistant Kenya 
52 Samuel Arimi University of Nairobi Associate professor Kenya 
53 Sanogo Moussa National Laboratory for Agricultural 
Development Support, Central 
Veterinary Laboratory of Bingerville 
Manager, Bacteriology Unit  Côte d‟Ivoire 
54 Shamsudeen Fagbo Ministry of Health Coordinator, zoonotic diseases  Saudi Arabia 
55 Stella Kiambi  Ministry of Livestock, Zoonotic 
Disease Unit 
Epidemiologist, veterinary officer Kenya 
56 Stephen Gathogo  Ministry of Livestock Development, 
Department of Veterinary Services 
Assistant director of veterinary 
services 
Kenya  
57 Steve Hennager USDA-ARS Microbiologist and team leader, 
Serology Section 
USA 
58 Steve Olsen USDA-ARS Veterinary medical officer,  
Infectious Bacterial Diseases 
Research Unit 
USA 
59 Sylvia Baluka Angubua  Makerere University, Department of 
Biosecurity & Veterinary Public 
Health 
Assistant lecturer Uganda 
60 Sylvia Omulo  KEMRI/CDC Research officer Kenya 
61 Tariku Jibat Beyene Addis Ababa University, Faculty of 
Veterinary Medicine 
Lecturer Ethiopia 
62 Tim Rowan GALVmed Scientific Advisor UK 
63 Tujuba Jergefa Oncho Addis Ababa University Veterinary epidemiologist Ethiopia 
64 Ulf Magnusson Swedish University of Agricultural 
Sciences 
Professor Sweden 
65 Waleed Saad El-din El-
Wahab 
Central Lab for Evaluation of 
Veterinary Biologics 
Senior researcher Egypt 
66 William de Glanville University of Edinburgh/ILRI PhD student/graduate fellow  Kenya 
67 William Mwebembezi  Mbarara Regional Veterinary 
Laboratory 
Senior veterinary officer Uganda 
68 Wilson Bertu  National Veterinary Research 
Institute 
Principal veterinary research 
officer 
Nigeria 
69 Wondu Kelbessa Addis Ababa University  Lecturer and head of department,  
animal sciences 
Ethiopia 
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Appendix 2: Workshop agenda 
Tuesday 29 January 2013 
07:00-08:00 Registration and sign up for breakout sessions 
08:00-08:30 
Opening session 
Welcome 
Eileen Thacker, USDA-ARS 
Azage Tegegne, CGIAR and ILRI 
Abdelkhalik Montasser, AU-IBAR 
Eileen Herrera, USDA-ARS 
John Graham, USAID 
08:30-08:50 
Presentation 
Brucellosis: The bugs and the disease 
Eileen Thacker, USDA-ARS, USA 
08:50-09:10 
Presentation 
Differential diagnosis of brucellosis serological reactions  
Steve Hennager, USDA-APHIS, USA 
09:10-09:30 
 
Presentation 
Epidemiology of brucellosis in ruminants: The basics and dynamics of the disease 
John Kaneene, Michigan State University, USA 
09:30-09:50 
Presentation 
Risk assessment for Brucella  
Anani Adéniran Bankolé, Direction of Livestock Services, Togo 
09:50-10:15 Break 
10:15-10:40 
Presentation 
Beneficial approaches for controlling brucellosis 
Steve Olsen, USDA-ARS, USA 
10:40-11:00 
Presentation 
Economics of Brucella control 
Bassirou Bonfoh, CSRS, Côte d'Ivoire 
11:00-11:20 
 
Presentation 
Laboratory biosafety and biosecurity issues related to Brucella research and diagnostics  
Joseph Kozlovac, USDA-ARS, USA 
11:20-11:40 
Presentation 
One Health Units and brucellosis in Kenya 
Stella Kiambi, Ministry of Livestock Development, Zoonotic Disease Unit, Kenya 
11:40-12:00 
 
Presentation 
Overview of brucellosis in the Middle East and AU-IBAR projects  
Abdelkhalik Montesser, AU-IBAR 
12:00:12:20 
Conclusions and overview of makeup of workshop 
Delia Grace, ILRI, Kenya 
12:20-13:30 Lunch 
13:30-15:30 
 
Breakout sessions 
 Diagnostics – Serological Screening Tests (Room 14) 
 Biosafety (Room 13) 
 Epidemiology – Large Ruminants (Auditorium 1) 
 Vaccination and Control – Small Ruminants (Auditorium 2) 
15:30-16:00 Break  
16:00-18:00 
 
Breakout sessions 
 Diagnostics – Confirmatory Tests (Room 14) 
 Epidemiology – Small Ruminants (Auditorium 1) 
 Vaccination and Control – Large Ruminants (Auditorium 2) 
18:30 Dinner 
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Wednesday 30 January 2013 
08:00-08:15 
Research plenary session  
Welcome 
Eileen Thacker, USDA-ARS, USA 
08:15-08:30 
Presentation  
Overview of ARS brucellosis research  
Steve Olsen, USDA-ARS, USA 
08:30-08:45 
Presentation  
Overview of Michigan State University brucellosis research in Africa 
John Kaneene, Michigan State University, USA 
08:45-09:00 
Presentations 
Studies on zoonoses in western Kenya 
Surprising results from investigations in brucellosis prevalence 
Eric Fèvre, ILRI, University of Edinburgh 
William de Glanville, ILRI, University of Edinburgh 
09:00-09:15 
 
Presentation 
Risk factors for Brucella seropositivity in cattle, goats and humans in Mbarara 
Edward Ssekawojwa, Lvantonde District Local Government, Uganda 
09:15-09:30 
 
Presentation 
Bovine brucellosis  
Tujuba Jergefa Oncho, Addis Ababa University, Ethiopia 
09:30-09:45 
 
Presentation 
The prevalence of antibodies against Brucella among breeding goats in relation to source 
William Mwebembezi, Mbarara Regional Veterinary Laboratory, Uganda 
09:45-10:30 Break  
10:30-12:30 
 
Breakout sessions 
Diagnostics – Serological Screening Tests (Room 14) 
Epidemiology – Large Ruminants (Auditorium 1) 
Vaccination and Control – Small Ruminants (Auditorium 2) 
12:30-13:30 Lunch 
13:30-15:30 
Breakout sessions 
Diagnostics – Confirmatory Tests (Room 14) 
Epidemiology – Small Ruminants (Auditorium 1) 
Vaccination and Control – Large Ruminants (Auditorium 2) 
Biosafety (Room 13) 
16:00-18:00 Open Q&A for speakers 
18:30- 19:30 
Reception and poster viewing 
 
 
Thursday 31 January 2013 
08:00-10:00 Breakout sessions report on information 
10:00-10:30 Break 
10:30-12:00 
Group discussion 
 Identifying gaps, problems and successes 
 Mapping initiatives 
 Key research questions 
12:00-13:00 Lunch 
13:00-15:00 
Conclusions and the way forward 
 Expectations 
 Opportunities 
 Collaborations 
 Resources  
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Appendix 3: Reports of the breakout sessions 
Appendix 3.1: Biosafety Breakout Sessions 
 
Joseph Kozlovac 
Agency Biosafety Officer, USDA ARS 
 
Introduction 
Brucellosis is the most common laboratory acquired disease so biosafety is of critical importance. In 
addition, Brucella species have the potential to be used as a biological weapon making laboratory 
security critical. A general overview was provided on the morning of the first day of the workshop. As 
part of the workshop, two breakout sessions focused on biosafety and laboratory security issues were 
held. Both sessions were co-chaired by Roger Pellé, ILRI Kenya and Joseph Kozlovac, USDA ARS. Each 
group was asked to: (1) identify gaps, problems and successes; (2) map initiatives; (3) identify key 
research questions; and (4) identify other major observations. The two breakout sessions had very 
robust discussions and while various positive activities had been reported by participants in relation to 
biosafety and laboratory biosecurity, participants from both breakout sessions identified similar 
challenges and gaps related to general biosafety and biosecurity issues as well as those specifically 
related to work with the causative agents of brucellosis. 
 
Key points 
 Information on current international biocontainment practices for work with Brucella 
 Current facilities and containment equipment for diagnostic and research laboratories 
 Current practices and use of personal protective equipment 
 Biosafety and laboratory security training needs 
 Current national and institutional biorisk management practices and structures 
 The major needs for improving biosafety or biorisk management practices in each country  
 
Current facilities/containment and uses  
 Kenya/Kabete: Biosafety Level (BSL)-2 lab, diagnostic work 
 KEMRI/CDC: Handle rabies, flu, rickettsia, Brucella; BSL-3 and BSL-2 labs 
 Kenya/DVS: BSL-3 lab, RVL, avian influenza (AI), brucellosis samples  
 Kenya/ZDU: Public health units do no direct work in lab.  
 Kenya/WHO: Serves as a focal point, no lab  
 Kenya/ILRI: Has a BSL-2 lab. Human and animal biological samples. Routine diagnostic 
 Ethiopia/National Animal Health Diagnostic Lab: BSL-2 and BSL-3 labs. The Food and 
Agricultural Organization constructed a BSL-3 lab. Interested in developing the ability to work 
on zoonotic diseases. East African reference laboratory for highly pathogenic avian influenza 
(HPAI) and Newcastle disease. Also bacterial serology lab on Brucella. 
 Egypt/Central Lab: Vaccine development, diagnosis, Brucella, BSL-2. Working on construction 
of a BSL-3 lab. 
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 Egypt/University of Cairo: Teaching veterinary public health, culture and diagnostic lab. 
 Cote d’Ivoire: Central Veterinary Laboratory (CVL). Diagnosis of bacterial diseases. Biosafety 
cabinets in labs. No lab classifications. 
 Tanzania: Was CVL, now an agency (Veterinary Laboratory Agency) with 20 centres. Central 
lab and vaccine production. Brucellosis and tuberculosis diagnostics. Centre for Infectious 
Diseases and Biotechnology (BSL-3).  
 Uganda/Makerere University: Makerere University Walter Reed Project – Emerging 
Infectious Diseases Laboratory, a BSL-2 laboratory with IsoArk, is situated within the College 
of Veterinary Medicine, Animal Resources and Biosecurity. It is involved in surveillance of 
emerging infectious diseases and antimicrobial resistance. It also provides support to 
microbiology laboratories in hospitals which are the sentinel sites for antimicrobial resistance 
surveillance in Uganda. 
 Uganda/National Agricultural Research Organization: Livestock research. Culture, serology 
and work with zoonotic diseases. Have budgeted for Mycobacterium bovis, B. abortus, E. coli. 
Working to reach enhanced BSL-2 capacity. Chairs biosafety group. 
 Nigeria/National Veterinary Research Institute: Diagnostics, vaccine production, extension. 
Department of bacterial research for brucellosis, BSL-2. BSL-3 for avian influenza. A reference 
laboratory for avian influenza for West Africa. 
 Nigeria: Research: no containment/standard wet lab  
 Ethiopia/Addis Ababa University: Microbiology lab but does not meet international 
biosafety requirements.  
 
Key gaps 
 
Laboratory equipment 
 Safety and laboratory equipment failure/part replacement/maintenance.  
 One common issue identified by participants was that available funding for livestock and 
agricultural laboratories was extremely minimal in comparison to human health. In most 
countries where laboratories have containment equipment like class II biological safety 
cabinets, it is difficult to maintain and annually certify them in accordance with internationally 
recognized standards. 
 A common identified problem related to equipment and facilities in general was power 
availability/disruptions. In addition to electrical grid availability, alternatives and the cost of 
installing, maintaining and fueling backup generators tends to be prohibitive in many cases. 
 
Way forward 
 Within countries or even on a regional basis, life science organizations should communicate 
various ideas and approaches.  
 Coordinate and synchronize times among institutions and within countries or regions for 
maintenance solutions to reduce service vendor travel costs and scheduling conflicts. 
 Evaluate the potential mechanisms to share certification costs such as utilizing collective 
bargaining (more than one institution) for contracting services with relevant vendors. 
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 Train and develop local capacity for maintenance and certification of laboratory equipment 
 Train scientists to perform routine maintenance but not certify or repair equipment.  
 
Diagnostic and research waste management  
 Waste management capacity varied widely among countries and facilities for both solid and 
liquid biohazardous waste generated as part of diagnostic and research work. 
 Solid biological/medical waste often needs to be transported to remote locations for 
treatment (typically incineration sometimes as far as 100 km away, according to Ugandan 
colleagues).  In many countries, the government labs have capacity for solid biohazardous 
waste management but academic labs lack capacity. For example, in Ethiopia in the university 
setting, biohazardous waste is left for cleaners which causes an increased risk of occupational 
exposure to this category of staff who are not necessarily trained on risks and appropriate 
procedures. Based upon the discussion, many universities are doing research on brucellosis 
and other aerosol-transmitted diseases but have no facilities to adequately treat and dispose 
of infectious waste. 
 Liquid waste is a particular problem. Untreated waste water ends up draining into main water 
bodies. Central liquid waste treatment for a facility is an expensive investment beyond most 
research and diagnostic facilities.  
 
Way forward 
 At the lab level, evaluate the ability to use available technology for point of use 
decontamination (for example, under sink continual flow systems). Labs can consider 
collecting liquids and autoclave or chemically treat this type of waste prior to disposal into a 
sewage system. There are some existing systems that exist that can treat this type of waste 
flow that are fairly cost effective.  
 Kenya: Has developed legislation on biosafety which governs how waste is disposed. Typically 
use a coloured bin approach to segregate wastes. Each district hospital is equipped with an 
incinerator for solid biomedical/medical waste.   
 Nigeria: Has a standard means of containing waste and transporting to an incinerator. There 
is a well-established process for handling waste and the individuals who handle waste are 
trained.  
 Potential to utilize regional biosafety associations to raise awareness and conduct training on 
biohazard waste disposal issues. 
 
Transportation of samples (cost, training, issues with ground transport) 
 Availability and cost of shipping materials is an issue as well as ensuring everyone involved in 
the transport is adequately trained. Maintaining chain of custody and cold chain of samples 
(impacts quality of samples and tissues received) is an ongoing challenge especially as it 
relates to ground transportation (which utilizes public transportation in some cases). Triple 
packaging is not utilized in many countries. 
 
Way forward 
 Evaluate the potential to ship samples via designated vehicles in villages. These could be 
operated by trained drivers/carriers on designated routes to transport samples to the 
laboratories. 
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 Tanzania: Capacity of labs is challenged. Two vets and two technicians in a zone (52 districts). 
At district level, there are veterinary centres. The zonal lab provides packaging services for 
samples. 
 Partner with other laboratories and via biosafety associations for provision of training and 
support for sample transportation issues. 
 
Coordination of biosafety training/knowledge 
 Need to identify core competencies needed for individuals working with Brucella species and 
identify what level of training is needed for each level from technicians to senior leadership. 
 Level of legislation/regulation/standards varies a great deal between countries and regions as 
does the political will to address biosafety issues related to Brucella work.  
 Access to appropriate personal protective equipment and the training to use it properly is 
needed. 
 There is a need to change biosafety culture within African institutions; in many cases accidents 
and illnesses not reported due to concerns about negative repercussions.  
 Ethiopia: University PhD student. Universities need training, infrastructure needed.  
 
Way forward 
 Establish biosafety associations in countries or encourage institutions to join the existing 
African Biosafety Association. These groups can serve as focal points to share information as 
well as educate and influence national and regional bodies with the goal of establishing 
national and regional policy infrastructures. 
 Develop competency standards for individuals working at various containment levels for 
biosafety. 
 Partner to train the trainers (internal and external) 
 Set up a biosafety training program for Africa: One suggested course of action was to present 
the issue to the Biosciences eastern and central Africa (BecA) hub at ILRI to create a biosafety 
training/forum as a new initiative. There was some robust discussion as to whether the BecA 
hub was the best fit for this initiative. Some of the participants expressed that a forum 
minimally at the level of East Africa was a positive idea and should allow discussion between 
neighbouring countries regarding biosafety activities.  
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Appendix 3.2: Epidemiology breakout sessions 
 
John B. Kaneene 
University Distinguished Professor of Epidemiology & Director of the Center for 
Comparative Epidemiology 
 
Introduction 
In the plenary sessions, there was a general overview on brucellosis presented by a number of experts. 
The areas covered included: epidemiology, diagnostic tests, disease control, and bio-safety. To follow 
up at an individual country level within topics, small breakout sessions were created covering four 
topics and assigned specific questions to address to ascertain gaps and needs. The epidemiology 
breakout sessions were divided into two major areas- large ruminants and small ruminants. Within the 
large and small ruminant sessions, the groups were assigned to discuss the following areas: key areas 
of concern and need, current initiatives on brucellosis in the different countries, gaps and research 
needs, main challenges, suggestions for a way forward, and success stories. 
 
Epidemiology of brucellosis in large ruminants 
 
Key points 
 Brucellosis is reportable in most countries but surveillance systems are weak  
 Distinguishing between the „problem‟ and „reality‟ is critical. As an example, we should not 
treat pastoralism as a problem but a reality and work to solve problems in that context 
 Aiming at a system where individually infected animals can be traced to their origin may not 
be affordable at this time and is not essential for making progress in disease control. 
 
Current initiatives on brucellosis 
 Kenya: A study on milk-borne zoonoses with the Department of Veterinary Services and the 
Kenya Agricultural Research Institute covering four districts. 
 Kenya: ZDU and CDC cross-sectional and longitudinal study on brucellosis in four key 
districts.  
 Uganda: National agriculture development on goats, including brucellosis control. 
 Uganda: Studies of brucellosis in cattle, goats, and humans in western areas. 
 South Africa: A brucellosis program has been developed which includes a manual for 
vaccinators. The government currently provides the vaccine. 
 Egypt: Test and slaughter programs are currently being conducted. 
 Nigeria: Active surveillance programs are being conducted by the National Veterinary 
Research Institute. 
 Nigeria: A project supported by the European Union that is investigating zoonotic diseases 
includes brucellosis. 
 Ethiopia: Creation of a meat and milk safety unit which will investigate brucellosis. 
 
Key gaps and research needs 
A number of gaps were identified by the different participating countries. In general, the gaps and 
research needs were very similar across all the countries. The following are representative of the gaps 
and research needs identified in selected countries: 
 
 Ethiopia: Funding to develop comprehensive surveillance and more uniform research 
 Ivory coast: Surveys to understand prevalence and impact (cross-sectional and abattoir) 
 Nigeria: Need increased animal and human data and to develop a control program 
 Egypt: Develop a national identification and traceability system for animals  
 Tanzania: Develop traceability and active surveillance programs 
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 Uganda: Determine the economic costs of disease in humans and animals and perform risk 
analysis on risks from disease; legislation to make brucellosis reportable; concrete data on 
human/animal disease 
 Côte d’Ivoire: Concrete data on the disease in humans and animals using a One Health 
approach 
 Kenya: Sensitization and awareness creation; active surveillance and information on 
prevalence across the entire country and then establish strategy; coordinated database 
 Togo: Need active surveillance 
 
Main challenges 
 Inadequate funding for compensation if animals are destroyed 
 Cultural habits of consuming raw milk 
 Vaccines not affordable to farmers and cold chain is difficult 
 Wildlife interface in some countries 
 Movement of people and animals difficult to restrict 
 Lack of adequate surveillance that concretely identifies severity of disease 
 
Suggestions for way forward 
 Target only high prevalence areas initially 
 Community animal health workers 
 Evidence on cost and benefit of control options as well as the cost of the disease 
 Re-establish prevalence of disease and determine socio-economic and public health impacts 
 
Key priorities 
 Establish baseline prevalence of disease 
 Determine economic burden of disease in animals and humans 
 Demonstrate the benefit of the control of brucellosis to the farmers. 
 Promote brucellosis as one of the best models for One Health problems 
 
Success stories 
 Kenya: Formation of ZDU and the resulting collaboration between medical doctors and 
veterinarians 
 South Africa: Sufficient allocation for disease control; standardized manual 
 Egypt: Local vaccine production for one year 
 Nigeria: Many surveys in the north of the country have shown prevalence of disease is 
increasing; vaccine is being produced; predominant infecting species identified (B. abortus 
biotype 1) 
 Ethiopia: The Meat and Milk Institute and Safety laboratories have been established to try to 
use university research to answer problems 
 
 
Epidemiology of brucellosis in small ruminants  
 
Key points 
 Small ruminants are often neglected 
 Brucellosis in goats is probably an important source of disease across East Africa 
 Need to involve economists, sociologists and gender specialists in evaluating economics and 
feasibility of control 
 A farmer-supported control scheme for brucellosis in small ruminants may not be viable and 
require subsidization based on public health concerns 
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 The problem of brucellosis in small and large ruminants and wildlife is intimately connected 
and needs to be evaluated in an integrated way 
 There is a need for a safe, cheap and effective vaccine that does not need a cold chain storage 
 We need to create awareness of the disease first, then talk about control next 
 Surveillance and control based on prior data from multiple diseases may be the best way to 
develop plans to control this disease. 
 
Current status  
 In most countries of Africa, there are more goats than sheep and goat meat is very popular. 
The husbandry can be viewed in two ways. One where goats are kept separate and the other 
where they are mixed with cattle and/or sheep, depending on the availability of land. 
Therefore, disease control strategies need to consider these differences of husbandry. 
 In many countries, women own most of the goats  
 Goats are mainly used for meat, money or festivals; a niche market for goat milk is developing  
 
Key gaps and research needs 
 Brucellosis in small ruminants is not recognized by many as a significant disease so need 
studies to determine status 
 Prevalence of brucellosis in goats needs to be established as well as the risk to human health 
 Confirmation of field observations suggesting that brucellosis spills over from intensive farms 
to surrounding small ruminants 
 Role of dogs and wildlife in the transmission of the disease needs to be established 
 The lack of diagnostic ability to type brucellosis agent makes accurate diagnosis and control 
difficult 
 
Suggestions for way forward 
 Need more epidemiology but needs to be incorporated into a strategy 
 Need a better understanding of transmission and health risks 
 Need to have greater rationale for control – human health, poverty, gender, export 
 USAID has a program to harmonize regulatory systems for a number of diseases 
 AU-IBAR is working at the regional level due to the importance of brucellosis to trade 
 Disease is not well known in communities, therefore there is need to raise awareness about 
the disease first, then design control strategies 
 Determine socio-economic impact of the disease so that policymakers can appreciate the 
disease 
 
Overall summary remarks 
 
1. There is a great need to determine the prevalence of brucellosis in both large and small 
ruminants. 
2. Participants stressed that data on the economic and public health impacts of brucellosis are 
urgently needed. 
3. Current surveillance systems in both animal and human populations regarding brucellosis are 
weak to non-existent in most African countries. 
4. Awareness of the economic and public health consequences of brucellosis need to be 
implemented. 
5. Affordable but reliable diagnostic tests need to be available so that scientists can adequately 
diagnose the disease in large and small ruminants, as well as humans. 
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Appendix 3.3: Brucellosis vaccination and control breakout sessions 
 
Steven Olsen 
National Animal Disease Center, USDA-ARS, Ames, IA 
 
Introduction 
Brucellosis remains a significant problem in Africa. In the workshop, the control and vaccination 
program discussions were divided into large and small ruminants due to differing production and 
management systems and vaccines and strategies for their use. Due to climate changes, economic 
factors and lifestyle, small ruminants are extremely common in Africa and are often raised in a pastoral 
management style. This allows close contact between animals and their human owners. In small 
ruminants, Brucella melitensis is the most common species isolated. To further compound its 
importance, it is also the most pathogenic to humans. 
 
Vaccination for B. melitensis through the use of Rev1 can be problematic as it is poorly attenuated; the 
bacteria will concentrate in the mammary gland following vaccination, making these animals a public 
health risk for a period of time. The Rev1 vaccine will cause clinical brucellosis in humans and 
abortions in pregnant animals. In contrast, the B. abortus strain 19 vaccine can cause clinical disease in 
animals and humans but is considered to be less pathogenic than Rev1. It is critical to consider the 
public health consequences when vaccinating any female lactating animals against Brucella species. 
The United States switched vaccine use from Strain 19 to RB 51 as it can be used to differentiate 
vaccinated from infected animals. Vaccination strategies vary from country to country, but overall it is 
best to vaccinate young animals and avoid vaccinating either pregnant or lactating animals. 
 
AU-IBAR is attempting to harmonize disease control for a number of transboundary diseases for 
export purposes. This is an attempt to strengthen the negotiations with the Arab peninsula. B. 
melitensis is one of the diseases on the list involved in this harmonization attempt. Information on 
prevalence in animals and humans is needed to support this initiative.  
 
While the topic of the breakout session was control and vaccination, epidemiology and serology were 
also discussed due to the integrated nature of this topic. In addition, human Brucella remained a 
constant sidebar to the discussions. Vaccination and control strategies are major challenges and many 
gaps and challenges were identified. However, a few potential paths forward were also identified. 
 
Vaccination and control strategies for small ruminants 
 
Key points 
 Need to characterize infections at the herd level 
 Enhance herd immunity in endemically infected areas through vaccination 
 Need enough data on incidence to convince policymakers to make brucellosis a priority 
disease to address and control; currently this is just one disease of many 
 Need a regional approach particularly due to pastoralist livestock movement 
 Since likelihood of vaccine programs is low, need to improve surveillance, education and 
outreach 
 
Current initiatives 
 Development of zoonotic disease units by CDC to improve interaction between public health 
and veterinary services in some countries; also a challenge in others 
 Somalia conveys information to animal health workers to educate pastoralists 
 Nigeria provides information to control transmission (see success stories) 
 AU-IBAR initiative to harmonize control strategies for export purposes 
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Key gaps and research needs 
 Education of people on public health concerns associated with brucellosis 
 Knowledge of which Brucella species is infecting domestic livestock in various countries/areas 
 Effectiveness of vaccine efficacy in different species (e.g. camels) is poorly characterized or 
documented 
 Little to no knowledge of duration of immunity of current vaccines 
 Appropriate age to vaccinate 
 Epidemiology of surveillance for accurate disease documentation – both humans and animals 
 Speciation and documentation of Brucella in small ruminants 
 Control strategies for areas with low incidence 
 What is the role of wildlife 
 Possible antibiotic therapy 
 Lack of reliable specific and sensitive diagnostic tests 
 Standardization of human brucellosis case definition 
 Standardization and consensus of government agencies on the importance of brucellosis 
 
Main challenges 
 In many countries (Somalia), need to reach out to pastoral people 
 Quarantine is needed in many countries (Tanzania) 
 If animals are vaccinated in negative areas, disease and titres may occur in those areas causing 
diagnostic and control problems 
 Harmonization of diagnostic tests and procedures 
 Need enough data to impress policymakers and need to communicate research results 
already collected 
 Porous borders (Nigeria has five) so requires regional approach 
 Lack of vaccine, cold chain issues and keeping vaccine cost affordable 
 Poor interaction between veterinary services and public health 
 Small agricultural budgets 
 Politics 
 Nigeria has a poor working relationship between veterinarians and public health officials. 
There is a lack of investigative centres, epidemiology and no trace-back capability. 
 
Way forward 
 Increase ZDUs or introduce in all countries 
 Update legislation and regulations to cover brucellosis 
 Develop national/regional strategic plans 
 Hold regional meeting to target approaches that can be harmonized between countries 
 Use community health workers to educate pastoralists – often the best way into a community 
 Develop strategies to perform trace-backs on human cases to the infected animals 
 Develop ongoing regulatory surveillance separate from research 
 Increase standardization of diagnostics 
 Identify the most vulnerable populations of animals and direct control towards them 
 Identify appropriate vaccination strategies 
 
Key priorities 
 Awareness and outreach to high-risk communities 
 Veterinary capacity 
 Integrated regional approach with research, policy development, harmonization of diagnostics  
 Developing new vaccines – combination products 
 Accurate data on disease incidence in animals and humans 
 Publication of research  
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Success stories 
 Nigeria currently provides educational pamphlets, holds gatherings with tribal chiefs and 
herding associations to convey information and uses culture to educate 
 Egypt vaccinated lambs with Rev1 by injection, followed by ocular administration and reduced 
disease occurrence by half 
 Rift Valley fever (RVF) has provided a template for veterinarians and public health officials to 
work together closely. As a result, they worked closely together during a recent brucellosis 
outbreak 
 First national conference on One Health held in Uganda 
 In Uganda, veterinarians and public health officials have been working closely together since 
the HPAI outbreak. There is a veterinarian in the Ministry of Health. This has allowed close 
collaborations on RVF, anthrax and rabies outbreaks. 
 
Vaccination and control strategies for large ruminants 
 
Many of the gaps, challenges, initiatives and key points are identical between large and small 
ruminants. 
 
Key points 
 Similar to small ruminants, there is a need to characterize the Brucella sp. infections to 
differentiate infection with B. abortus and B. melitensis 
 Need to pursue regional approaches to control 
 Determine prevalence to ascertain the exact vaccination strategy to pursue 
 No current guidelines for vaccinating camels for either species of Brucella. 
 
Current initiatives 
 South Africa currently requires cattle to be vaccinated as calves; vaccination of older animals is 
illegal. They use both RB 51 and Strain 19 vaccines. Only cattle are vaccinated and they have a 
test and cull program. Positive animals are branded, although they often disappear. 
 Egypt previously vaccinated 500,000 in the Delta area. However, since the political revolution, 
maintaining the program has become problematic. The government purchases the vaccines 
and also practices test and slaughter programs. 
 Tanzania has control programs in government herds (test and slaughter) 
 Some initiatives in Uganda used students to conduct research surveillance but were short-
lived. 
 
Key gaps and research needs 
 Need to establish government regulated surveillance programs 
 Regionalization/harmonization of policies 
 Determine prevalence in large ruminants using appropriate epidemiologic surveys 
 Standardize diagnostic assays 
 Establish vaccine strategies that will be effective for nomadic and adult animals 
 
Main challenges 
 Most countries lack formal surveillance programs 
 Significant numbers of herds belong to nomadic peoples so difficult to regulate 
 
Suggestions for way forward 
 Establish effective movement control between countries – a regional approach 
 Determine the actual prevalence in animals and humans within the country and use this to 
establish regulations and policies 
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Key priorities 
 Brucellosis in large ruminants needs to be addressed 
 Epidemiology 
 Vaccine and control strategies established 
 Regulations and policies developed 
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Appendix 3.4: Brucellosis diagnostic tests - Screening and 
confirmatory 
 
Steven Hennager 
Team Leader, Serology Section, Diagnostic Bacteriology 
National Veterinary Services Laboratory, APHIS, Ames, IA 
 
 
Introduction 
An overview presentation was made in plenary on diagnostic assays for brucellosis. Diagnosis of the 
infection is a challenge in both humans and animals. There are a number of different types of 
diagnostic tests with different sensitivities and specificities. Most of the assays concentrate on 
detecting antibodies in fluids such as serum rather than isolating or detecting the organism. However, 
tests such as polymerase chain reaction (PCR) assays are increasing in availability and usefulness in 
detecting the organism. An advantage of tests that detect the organism is that they allow speciation 
of the organism for better interpretation and control strategies. In addition, there are differences in 
the ability to detect infection with the various Brucella species and, in the case of animals, species of 
animals. However, the lack of specificity – and thus cross-reactivity with other organisms – is 
problematic. Another major concern is the high risk of laboratory acquired infection for laboratory 
personnel involved in isolating or performing diagnostics for Brucella. All of these factors make the 
diagnosis of brucellosis in humans and animals challenging. 
 
Key points  
 In high incidence regions, serologic tests need sensitivity more than specificity. In low 
incidence regions, serologic tests need more specificity than sensitivity. 
 All agglutination test reactions must be compared to the control sera reactions. 
 No serologic test can determine if the antibody titre is due to vaccine or a Brucella species 
field strain infection. 
 Serologic tests must be reliable and economical for use in a control program. 
 
Current initiatives for diagnostics 
 Many regional studies have been completed throughout Africa. It is difficult to interpret 
findings between animal and human brucellosis due to variation in study design and 
diagnostic assay. 
 Brucella melitensis, frequently associated with small ruminants, has been isolated from cattle.  
 Human treatment is difficult due to the frequent re-exposure to Brucella organisms. 
 A variety of confirmatory tests are available but only in a few laboratories.  
 Export animal centres are making decisions based on the results of screening tests without a 
highly specific confirmatory serologic test.  
 
Key gaps and research needs  
A significant number of gaps were identified that went across borders and were consistent with all of 
the African participants. The following are representative of those gaps and needs. 
 
 A good, reliable and economic confirmatory test for livestock 
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 Serologic tests need to be validated in species other that bovine or porcine. 
 Human testing needs a more specific test than the slide agglutination test. 
 Can animal assays be used on human samples? 
 Laboratory test results need to be combined with epidemiologic evidence before a positive 
brucellosis diagnosis can be made. 
 How will a vaccination program affect the diagnostic tests used in diagnosis of the disease? 
 For import and export testing with low incidence of brucellosis, what serologic tests can give a 
specific interpretation of the disease status of the animals tested? 
 Develop case definitions and harmonization of test procedures, especially in areas where 
multiple diseases may complicate the diagnosis of brucellosis. 
 Quality control for diagnostic labs and tests 
 Camel and goat milk is homogenized so the ring test is not effective. An indirect enzyme-
linked immunosorbent assay (ELISA) test is needed for accurate testing. 
 Confirmatory tests must be more specific than screening tests. The fluorescent polarization 
assay is highly specific, simple and portable. However, it does not appear to work as well with 
human testing and Brucella melitensis. Other confirmatory tests, such as competitive ELISA 
and complement fixation test, should be investigated.  
 
Main challenges 
 Lack of a good diagnostic test that can be used in all species of animals and humans 
 Lack of quality control for diagnostic tests 
 Reagents used for tests are often of poor quality and the technicians lack the skills to 
accurately perform the tests 
 Many false positive serologic results occur for tests on humans, and few to no confirmatory 
testing is performed 
 False positive results for animals in the export/import market from areas of low incidence of 
brucellosis. 
 PCR works best with bacteraemia and is more useful in human cases 
 Isolation of bacteria from serological positive animals is successful in only approximately 40% 
of the animals in the USA. 
 Treatment of humans with antibiotics needs to be continued for a full eight weeks.  Treatment 
may be compromised if the patient becomes re-infected during the course of treatment. 
 
Suggestions for a way forward 
 Investigate combining human and animal diagnostic laboratories in the One Health Initiative. 
 Use the brucellosis 8% card for B. abortus and the 3% card for B. melitensis. 
 Increase sampling of bulk tanks with milk ring test. 
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Key priorities 
 Improve quality control of reagents and training of personnel for quality control 
 For import/export controls, develop a testing standard operating practice to enhance test 
accuracy 
 Work to develop reference laboratories for confirmatory screening 
 Work with epidemiologists to design studies that will provide accurate and reliable data 
 Develop an indirect ELISA test that can be used to accurately test camel and goat milk. 
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Appendix 4: List of presentations  
All the presentations are available online on the workshop website, http://brucellosis-
africa.wikispaces.com/ and in the ILRI repository, http://cgspace.cgiar.org/handle/10568/32725. For 
ease of reference, the titles of the presentations listed below are linked to SlideShare. 
Workshop overview 
Brucellosis: The bugs and the disease: Eileen Thacker 
 
Differential diagnosis of brucellosis serological reactions: Steve Hennager 
 
Epidemiology of brucellosis in ruminants: The basics and dynamics of the disease: John Kaneene 
 
Risk assessment for Brucella: Anani Adéniran Bankolé 
 
Beneficial approaches for controlling brucellosis: Steve Olsen 
 
Economics of Brucella control: Bassirou Bonfoh 
 
Laboratory biosafety and biosecurity issues related to Brucella research and diagnostics: Joseph 
Kozlovac 
 
One Health units and brucellosis in Kenya: Stella Kiambi 
 
Brucellosis: Past, present and future in the Middle East and Africa: Abdelkhalik Montasser 
 
Research plenary session  
Overview of brucellosis research in the USDA Infectious Bacterial Diseases Unit: Steve Olsen 
 
Overview of Michigan State University brucellosis research in Africa: John Kaneene 
 
A framework for understanding zoonoses at the livestock-human interface in western Kenya: Eric Fèvre 
 
The (short) story of brucellosis in western Kenya: William de Glanville 
 
Risk factors for Brucella seropositivity in cattle, goats and humans in Mbarara: Edward Ssekawojwa 
 
Epidemiological study of bovine brucellosis in Ethiopia: Tujuba Jergefa Oncho 
 
The prevalence of antibodies against Brucella among breeding goats in relation to source: A case 
study in Mbarara District, South Western Uganda:  William Mwebembezi 
 
Vaccination and control breakout session points 
 
Overview of large animal brucellosis control strategies: Steve Olsen  
 
Overview of small animal brucellosis control strategies: Steve Olsen 
 
